Skip to main content
. 2014 Jun 17;38(3):230–239. doi: 10.4093/dmj.2014.38.3.230

Table 4.

Prescription status of therapy for diabetes in patients using insulin and oral hypoglycemic agent

graphic file with name dmj-38-230-i004.jpg

OHA, oral hypoglycemic agent; Met, metformin; AGI, α-glucosidase inhibitor; Glinide, meglitinide; SU, sulfonylurea; TZD, thiazolidinedione; DPP4I, dipeptidyl peptidase 4 inhibitor.